KAYLI BISCHOFF: Open Payments
NPI 1306599485 · OCOEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,868 in 138 payments from 22 companies in 2025. Trend: 2023 $3,546 · 2024 $3,458 · 2025 $3,868
Food & beverage: $3,759Education: $109
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $729 |
| Janssen Biotech, Inc. | 20 | $490 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $394 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $370 |
| Lilly USA, LLC | 10 | $256 |
| Madrigal Pharmaceuticals | 10 | $218 |
| Novo Nordisk Inc | 4 | $179 |
| QOL Medical, LLC | 4 | $177 |
| Intra-Sana Laboratories | 1 | $150 |
| Ardelyx, Inc. | 6 | $149 |
Products named: TREMFYA, ENTYVIO, SKYRIZI, OMVOH, REZDIFFRA, XIFAXAN, RINVOQ, Wegovy.
Industry payments across FL — which companies pay providers there.
